Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Terminal ballistics of kinase inhibitors: there are no magic bullets.
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
AP1S2 is mutated in X-linked Dandy-Walker malformation with intellectual disability, basal ganglia disease and seizures (Pettigrew syndrome).
Pathology of experimental erysipelothrix insidiosa infection in rats.
Toll-like Receptor Agonist Conjugation: A Chemical Perspective.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Toll-like Receptor Agonist Conjugation: A Chemical Perspective.
Toll-like Receptor Agonist Conjugation: A Chemical Perspective. Bioconjug Chem. 2018 03 21; 29(3):587-603.
View in:
PubMed
subject areas
Adaptive Immunity
Adjuvants, Immunologic
Animals
Chemistry Techniques, Synthetic
Humans
Immunity, Innate
Models, Molecular
Toll-Like Receptors
Vaccines, Synthetic
authors with profiles
Aaron Esser-Kahn